Company Filing History:
Years Active: 1992-1999
Title: Sonia J Heiber: Innovator in Drug Delivery Systems
Introduction
Sonia J Heiber is a prominent inventor based in Salt Lake City, UT (US). She has made significant contributions to the field of drug delivery systems, holding a total of nine patents. Her work focuses on innovative methods for administering glucagon-like insulinotropic peptides, which are crucial for various therapeutic applications.
Latest Patents
One of her latest patents involves the buccal delivery of glucagon-like insulinotropic peptides. This patent describes drug delivery systems and methods for administering these peptides to the buccal mucosa for effective transmucosal drug delivery. The systems include a drug composition that contains an effective amount of the glucagon-like insulinotropic peptide and a permeation enhancer to facilitate the peptide's absorption through the buccal mucosa. These systems can be formulated in various forms, such as creams, gels, and ointments, or as devices like tablets, patches, and troches. A preferred glucagon-like insulinotropic peptide mentioned in her patent is GLP-1(7-36)amide.
Another significant patent focuses on compositions and methods for buccal delivery of pharmaceutical agents. This composition is designed for transmucosally administering a drug to the oral cavity. It features an adhesive layer made of a hydrophilic polymer that adheres to the oral cavity's tissue when wet. The drug-containing layer, which may include a permeation enhancer, is adapted to ensure effective drug transfer to the mucosal tissue. Preferred drugs in this patent also include peptides, such as glucagon-like insulinotropic peptides.
Career Highlights
Sonia J Heiber has established herself as a key figure in her field through her innovative research and development efforts. She is currently associated with Theratech, Inc., where she continues to advance her work in drug delivery technologies.
Collaborations
Throughout her career, Sonia has collaborated with notable professionals, including Charles D Ebert and Dinesh C Patel. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Sonia J Heiber is a trailblazer in the field of drug delivery systems, with a focus on glucagon-like insulinotropic peptides. Her innovative patents and contributions to Theratech, Inc. highlight her commitment to improving pharmaceutical delivery methods. Her work continues to impact the medical field positively.